THYMIDINE PHOSPHORYLASE OVEREXPRESSION IN ORAL CANCER TISSUE AS A TARGET OF CAPECITABINE: THE PRE-CLINICAL RATIONAL

被引：0
|
作者：
Ranieri, G. [1 ]
Patruno, R. [1 ]
Saponaro, G. [1 ]
Console, G. [1 ]
Paradiso, A. [1 ]
Grammatica, L. [1 ]
机构：
[1] Natl Canc Inst Bari, Bari, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] THYMIDINE PHOSPHORYLASE CHARACTERIZATION IN HEALTHY AND CANCEROUS PANCREATIC TISSUE: AN EMERGING TARGET FOR CAPECITABINE
    Pellecchia, A.
    Labriola, A.
    Patruno, R.
    Daprile, R.
    Scotto, F.
    De Ceglie, A.
    Martino, D.
    Valerio, P.
    Zito, A. F.
    Ranieri, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 73 - 73
  • [2] Localization of thymidine phosphorylase in breast cancer tissue
    Kobayashi M.
    Sugimoto T.
    Okabayashi T.
    Okamoto K.
    Namikawa T.
    Tochika N.
    Moriki T.
    Araki K.
    Medical Molecular Morphology, 2005, 38 (2) : 112 - 117
  • [3] Determinants of capecitabine efficacy in metastatic breast cancer: The role of thymidine phosphorylase
    Andreetta, C.
    Valent, F.
    Pascoletti, G.
    Sottile, R.
    Minisini, A. M.
    Russo, S.
    Fasola, G.
    Pizzolitto, S.
    Di Loreto, C.
    Puglisi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Making Capecitabine Targeted Therapy for Breast Cancer: Which is the Role of Thymidine Phosphorylase?
    Bonotto, Marta
    Bozza, Claudia
    Di Loreto, Carla
    Osa, Etin-Osa O.
    Poletto, Elena
    Puglisi, Fabio
    CLINICAL BREAST CANCER, 2013, 13 (03) : 167 - 172
  • [5] Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
    Andreetta, C.
    Puppin, C.
    Minisini, A.
    Valent, F.
    Pegolo, E.
    Damante, G.
    Di Loreto, C.
    Pizzolitto, S.
    Pandolfi, M.
    Fasola, G.
    Piga, A.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 265 - 271
  • [6] Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer
    Layman, Rachel M.
    Thomas, Dafydd G.
    Griffith, Kent A.
    Smerage, Jeffrey B.
    Helvie, Mark A.
    Roubidoux, Marilyn A.
    Diehl, Kathleen M.
    Newman, Lisa A.
    Sabel, Michael S.
    Hayman, James A.
    Pierce, Lori J.
    Hayes, Daniel F.
    Schott, Anne F.
    CLINICAL CANCER RESEARCH, 2007, 13 (14) : 4092 - 4097
  • [7] Taking aim at a challenging target in pre-clinical models of prostate cancer
    Arendt, Lisa M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S88 - S90
  • [8] Clinical impact of thymidine phosphorylase expression in gastric cancer
    Noguchi, T
    Fujiwara, S
    Takeno, S
    Kai, S
    Mizuta, A
    Nagao, Y
    Uchida, Y
    ONCOLOGY REPORTS, 2003, 10 (03) : 561 - 566
  • [9] Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin
    Petrioli, Roberto
    Bargagli, Gianluca
    Lazzi, Stefano
    Pascucci, Alessandra
    Francini, Edoardo
    Bellan, Cristiana
    Conca, Raffaele
    Martellucci, Ignazio
    Fiaschi, Anna Ida
    Lorenzi, Bruno
    Francini, Guido
    ANTI-CANCER DRUGS, 2010, 21 (03) : 313 - 319
  • [10] Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase
    Koizumi, Wasaburo
    Okayasu, Isao
    Hyodo, Ichinosuke
    Sakamoto, Junichi
    Kojima, Hiroshi
    ANTI-CANCER DRUGS, 2008, 19 (08) : 819 - 824
12345